Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kreutzberg, 1996, Microglia: a sensor for pathological events in the CNS, Trends Neurosci., 19, 312, 10.1016/0166-2236(96)10049-7
Hanisch, 2007, Microglia: active sensor and versatile effector cells in the normal and pathologic brain, Nat. Neurosci., 10, 1387, 10.1038/nn1997
Davalos, 2005, ATP mediates rapid microglial response to local brain injury in vivo, Nat. Neurosci., 8, 752, 10.1038/nn1472
Gao, 2003, Novel anti-inflammatory therapy for Parkinson's disease, Trends Pharmacol. Sci., 24, 395, 10.1016/S0165-6147(03)00176-7
Block, 2007, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat. Rev. Neurosci., 8, 57, 10.1038/nrn2038
Wyss-Coray, 2002, Inflammation in neurodegenerative disease–a double-edged sword, Neuron, 35, 419, 10.1016/S0896-6273(02)00794-8
Aktas, 2005, Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL, Neuron, 46, 421, 10.1016/j.neuron.2005.03.018
Liu, 2003, Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention, J. Pharmacol. Exp. Ther., 304, 1, 10.1124/jpet.102.035048
Purisai, 2007, Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration, Neurobiol. Dis., 25, 392, 10.1016/j.nbd.2006.10.008
Schwartz, 2004, A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis, Trends Pharmacol. Sci., 25, 407, 10.1016/j.tips.2004.06.010
Glezer, 2007, Neuroprotective role of the innate immune system by microglia, Neuroscience, 147, 867, 10.1016/j.neuroscience.2007.02.055
Schwartz, 2008, Immunity to self and self-maintenance: a unified theory of brain pathologies, Trends Immunol., 29, 211, 10.1016/j.it.2008.01.003
Simard, 2006, Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease, Neuron, 49, 489, 10.1016/j.neuron.2006.01.022
Ding, 2004, Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor, J. Neurochem., 89, 776, 10.1111/j.1471-4159.2004.02415.x
McGeer, 1988, Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains, Neurology, 38, 1285, 10.1212/WNL.38.8.1285
Gao, 2002, Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease, J. Neurochem., 81, 1285, 10.1046/j.1471-4159.2002.00928.x
Qin, 2007, Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration, Glia, 55, 453, 10.1002/glia.20467
Gao, 2003, Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease, FASEB J., 17, 1954, 10.1096/fj.03-0109fje
McGeer, 2003, Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration, Ann. Neurol., 54, 599, 10.1002/ana.10728
Langston, 1999, Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure, Ann. Neurol., 46, 598, 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F
Wu, 2002, Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease, J. Neurosci., 22, 1763, 10.1523/JNEUROSCI.22-05-01763.2002
Zhang, 2004, Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase, FASEB J., 18, 589, 10.1096/fj.03-0983fje
Liu, 2000, Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation, J. Pharmacol. Exp. Ther., 293, 607
Sriram, 2002, Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease, FASEB J., 16, 1474, 10.1096/fj.02-0216fje
Wu, 2006, The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice, Proc. Natl. Acad. Sci. U. S. A., 103, 12132, 10.1073/pnas.0603670103
Klegeris, 2007, Therapeutic approaches to inflammation in neurodegenerative disease, Curr. Opin. Neurol., 20, 351, 10.1097/WCO.0b013e3280adc943
McGeer, 2007, NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies, Neurobiol. Aging, 28, 639, 10.1016/j.neurobiolaging.2006.03.013
Chen, 2005, Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease, Ann. Neurol., 58, 963, 10.1002/ana.20682
Weggen, 2007, NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?, Trends Pharmacol. Sci., 28, 536, 10.1016/j.tips.2007.09.004
Nicoll, 2000, Association of interleukin-1 gene polymorphisms with Alzheimer's disease, Ann. Neurol., 47, 365, 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G
Schulte, 2002, Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease, Neurosci. Lett., 326, 70, 10.1016/S0304-3940(02)00301-4
Tai, 2007, Microglial activation in presymptomatic Huntington's disease gene carriers, Brain, 130, 1759, 10.1093/brain/awm044
Zhang, 2005, Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease, FASEB J., 19, 533, 10.1096/fj.04-2751com
Kim, 2007, A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation, FASEB J., 21, 179, 10.1096/fj.06-5865com
Zecca, 2003, Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics, Trends Neurosci., 26, 578, 10.1016/j.tins.2003.08.009
Floden, 2005, Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors, J. Neurosci., 25, 2566, 10.1523/JNEUROSCI.4998-04.2005
Rubartelli, 2007, Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox, Trends Immunol., 28, 429, 10.1016/j.it.2007.08.004
Butovsky, 2005, Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective, Mol. Cell. Neurosci., 29, 381, 10.1016/j.mcn.2005.03.005
Zhang, 2007, Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein, Glia, 55, 1178, 10.1002/glia.20532
Qin, 2002, Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species, J. Neurochem., 83, 973, 10.1046/j.1471-4159.2002.01210.x
Monsonego, 2003, Immunotherapeutic approaches to Alzheimer's disease, Science, 302, 834, 10.1126/science.1088469
Goodwin, 1997, Integrin Mac-1 and beta-amyloid in microglial release of nitric oxide, Brain Res., 768, 279, 10.1016/S0006-8993(97)00653-7
Pei, 2007, MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity, Glia, 55, 1362, 10.1002/glia.20545
Ross, 2000, Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein, Crit. Rev. Immunol., 20, 197, 10.1615/CritRevImmunol.v20.i3.20
Ross, 1993, CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions, Clin. Exp. Immunol., 92, 181, 10.1111/j.1365-2249.1993.tb03377.x
Wright, 1986, Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide, J. Exp. Med., 164, 1876, 10.1084/jem.164.6.1876
Mayadas, 2005, Neutrophil beta2 integrins: moderators of life or death decisions, Trends Immunol., 26, 388, 10.1016/j.it.2005.05.002
Akiyama, 1990, Brain microglia constitutively express beta-2 integrins, J. Neuroimmunol., 30, 81, 10.1016/0165-5728(90)90055-R
Liberatore, 1999, Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease, Nat. Med., 5, 1403, 10.1038/70978
Hu, 2007, MAC1 mediates MPP+-induced reative microgliosis: role in neurodegeneration, Neuroscience, 238, 685
Coxon, 1996, A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation, Immunity, 5, 653, 10.1016/S1074-7613(00)80278-2
Adams, 2007, The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease, J. Exp. Med., 204, 571, 10.1084/jem.20061931
Qin, 2004, NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia, J. Biol. Chem., 279, 1415, 10.1074/jbc.M307657200
Wu, 2005, The role of microglia in paraquat-induced dopaminergic neurotoxicity, Antioxid. Redox Signal., 7, 654, 10.1089/ars.2005.7.654
Gao, 2003, Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons, J. Neurosci., 23, 6181, 10.1523/JNEUROSCI.23-15-06181.2003
Block, 2004, Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase, FASEB J., 18, 1618, 10.1096/fj.04-1945fje
Park, 2007, Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain, J. Cereb. Blood Flow Metab., 27, 1908, 10.1038/sj.jcbfm.9600491
Lynch, 1999, ‘Outside-in’ signalling mechanisms underlying CD11b/CD18-mediated NADPH oxidase activation in human adherent blood eosinophils, Br. J. Pharmacol., 128, 1149, 10.1038/sj.bjp.0702892
Le Cabec, 2002, Complement receptor 3(CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively, J. Immunol., 169, 2003, 10.4049/jimmunol.169.4.2003
Qian, 2006, Interleukin-10 protects lipopolysaccharide-induced neurotoxicity in primary midbrain cultures by inhibiting the function of NADPH oxidase, J. Pharmacol. Exp. Ther., 319, 44, 10.1124/jpet.106.106351
Kremlev, 2005, Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures, J. Neuroimmunol., 162, 71, 10.1016/j.jneuroim.2005.01.010
Makwana, 2007, Endogenous transforming growth factor beta 1 suppresses inflammation and promotes survival in adult CNS, J. Neurosci., 27, 11201, 10.1523/JNEUROSCI.2255-07.2007
Marchetti, 2005, To be or not to be (inflamed)–is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?, Trends Pharmacol. Sci., 26, 517, 10.1016/j.tips.2005.08.007
Pluchino, 2005, Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism, Nature, 436, 266, 10.1038/nature03889
Perry, 2007, Systemic infections and inflammation affect chronic neurodegeneration, Nat. Rev. Immunol., 7, 161, 10.1038/nri2015
Kyrkanides, 2001, Enhanced glial activation and expression of specific CNS inflammation-related molecules in aged versus young rats following cortical stab injury, J. Neuroimmunol., 119, 269, 10.1016/S0165-5728(01)00404-0
Mrak, 2005, Glia and their cytokines in progression of neurodegeneration, Neurobiol. Aging, 26, 349, 10.1016/j.neurobiolaging.2004.05.010
Nitsch, 2004, Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue, J. Neurosci., 24, 2458, 10.1523/JNEUROSCI.4703-03.2004
Nguyen, 2004, Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis, J. Neurosci., 24, 1340, 10.1523/JNEUROSCI.4786-03.2004
Ek, 2001, Inflammatory response: pathway across the blood-brain barrier, Nature, 410, 430, 10.1038/35068632
Pavlov, 2004, Neural regulators of innate immune responses and inflammation, Cell. Mol. Life Sci., 61, 2322, 10.1007/s00018-004-4102-3
Nguyen, 2002, Innate immunity: the missing link in neuroprotection and neurodegeneration?, Nat. Rev. Neurosci., 3, 216, 10.1038/nrn752
Ling, 2006, Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally, Exp. Neurol., 199, 499, 10.1016/j.expneurol.2006.01.010
Hirsch, 2005, Neuroinflammatory processes in Parkinson's disease, Parkinsonism Relat. Disord., 11, S9, 10.1016/j.parkreldis.2004.10.013
Peng, 2005, Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia, Brain Res. Mol. Brain Res., 134, 162, 10.1016/j.molbrainres.2004.10.021
Chen, 2006, Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes, Mol. Psychiatry, 11, 1116, 10.1038/sj.mp.4001893
Benner, 2004, Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease, Proc. Natl. Acad. Sci. U. S. A., 101, 9435, 10.1073/pnas.0400569101
Angelov, 2003, Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis, Proc. Natl. Acad. Sci. U. S. A., 100, 4790, 10.1073/pnas.0530191100
Gehrmann, 1996, Microglia: a sensor to threats in the nervous system?, Res. Virol., 147, 79, 10.1016/0923-2516(96)80220-2
Gehrmann, 1995, Microglia: intrinsic immuneffector cell of the brain, Brain Res. Brain Res. Rev., 20, 269, 10.1016/0165-0173(94)00015-H
Carson, 1999, Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation, J. Neurosci. Res., 55, 127, 10.1002/(SICI)1097-4547(19990101)55:1<127::AID-JNR14>3.0.CO;2-2
Streit, 2004, Microglia and neuroinflammation: a pathological perspective, J. Neuroinflammation, 1, 14, 10.1186/1742-2094-1-14
Kordower, 2003, In vivo gene delivery of glial cell line–derived neurotrophic factor for Parkinson's disease, Ann. Neurol., 53, S120, 10.1002/ana.10485
Trapp, 2007, Evidence for synaptic stripping by cortical microglia, Glia, 55, 360, 10.1002/glia.20462
Piet, 2004, Physiological contribution of the astrocytic environment of neurons to intersynaptic crosstalk, Proc. Natl. Acad. Sci. U. S. A., 101, 2151, 10.1073/pnas.0308408100
Oliet, 2004, Glial modulation of synaptic transmission: Insights from the supraoptic nucleus of the hypothalamus, Glia, 47, 258, 10.1002/glia.20032